ALNY vs PLBC · P/E 76, rev $1.29B vs P/E 9.0, rev $59.7M
Alnylam Pharmaceuticals Inc (ALNY) versus Plumas Bancorp (PLBC) — a side-by-side from cached financials, not a winner call.
Alnylam Pharmaceuticals Inc (ALNY) is a biotechnology company listed on US.
Plumas Bancorp (PLBC) is a banks - regional company listed on US.
Latest reported ALNY revenue for 2026-06-30 was $1.29B. Net income was $164.5M. Revenue was up 3.4% from 2025-09-30 to 2026-06-30. ALNY currently screens at market cap $40.46B and trailing P/E 76.3.
Latest reported PLBC revenue for 2026-06-30 was $59.7M. Net income was $19.7M. PLBC currently screens at market cap $263.5M and trailing P/E 9.0.
ALNY currently screens at market cap $40.46B and trailing P/E 76.3. PLBC currently screens at market cap $263.5M and trailing P/E 9.0.
Not investment advice. Open the ALNY and PLBC stock pages for the full models.
Not investment advice.